Long-term efficacy and safety of intravesical BCG-Moreau Polish substrain in the treatment of non-muscle invasive bladder cancer

20240 citationsJournal Articlegreen Open Access

Authors

Wiktor Bursiewicz

Monika Złotkiewicz

Wojciech Krajewski

Krzysztof Tupikowski

Jan Adam Kołodziej · Wroclaw Medical University

R. Jünemann

Tobias Niels Mudra · Apogepha Arzneimittel (Germany)

Stefanie Witecy · Apogepha Arzneimittel (Germany)

Tomasz Szydełko

Anna Kołodziej

Abstract

BCG Moreau was effective and safe in the treatment of patients with intermediate- or high-risk non-muscle invasive bladder cancer. There was no statistically significant difference in treatment outcome between BCG Moreau and BCG RIVM strains based on real-world data.

Topics & Keywords

Bladder and Urothelial Cancer Treatments Urinary Bladder and Prostate Research Urinary and Genital Oncology Studies

UN Sustainable Development Goals

Zero hunger

Publication Details

Published in: Editor-in-Chief s Voice List of Authors is an Important Element in a Scientific Publication

Volume 77, Issue 2, pp. 196-202

DOI: 10.5173/ceju.2024.01

Field-Weighted Citation Impact: 0.00